420 related articles for article (PubMed ID: 36675282)
21. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
Wu YY; Chiu FL; Yeh CS; Kuo HC
Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial dysfunction in neurodegenerative diseases: A focus on iPSC-derived neuronal models.
Trombetta-Lima M; Sabogal-Guáqueta AM; Dolga AM
Cell Calcium; 2021 Mar; 94():102362. PubMed ID: 33540322
[TBL] [Abstract][Full Text] [Related]
23. Genetically encoded fluorescent biosensors for live-cell visualization of protein phosphorylation.
Oldach L; Zhang J
Chem Biol; 2014 Feb; 21(2):186-97. PubMed ID: 24485761
[TBL] [Abstract][Full Text] [Related]
24. Glaucoma as a Neurodegenerative Disease Caused by Intrinsic Vulnerability Factors.
Artero-Castro A; Rodriguez-Jimenez FJ; Jendelova P; VanderWall KB; Meyer JS; Erceg S
Prog Neurobiol; 2020 Oct; 193():101817. PubMed ID: 32360241
[TBL] [Abstract][Full Text] [Related]
25. A high-throughput multiparameter screen for accelerated development and optimization of soluble genetically encoded fluorescent biosensors.
Koveal D; Rosen PC; Meyer DJ; Díaz-García CM; Wang Y; Cai LH; Chou PJ; Weitz DA; Yellen G
Nat Commun; 2022 May; 13(1):2919. PubMed ID: 35614105
[TBL] [Abstract][Full Text] [Related]
26. Patient-Specific iPSCs-Based Models of Neurodegenerative Diseases: Focus on Aberrant Calcium Signaling.
Grekhnev DA; Kaznacheyeva EV; Vigont VA
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054808
[TBL] [Abstract][Full Text] [Related]
27. Cellular models of alpha-synuclein toxicity and aggregation.
Delenclos M; Burgess JD; Lamprokostopoulou A; Outeiro TF; Vekrellis K; McLean PJ
J Neurochem; 2019 Sep; 150(5):566-576. PubMed ID: 31265132
[TBL] [Abstract][Full Text] [Related]
28. The Cutting Edge of Disease Modeling: Synergy of Induced Pluripotent Stem Cell Technology and Genetically Encoded Biosensors.
Valetdinova KR; Malankhanova TB; Zakian SM; Medvedev SP
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440164
[TBL] [Abstract][Full Text] [Related]
29. Central nervous system organoids for modeling neurodegenerative diseases.
Hou PS; Kuo HC
IUBMB Life; 2022 Aug; 74(8):812-825. PubMed ID: 35102668
[TBL] [Abstract][Full Text] [Related]
30. Enhanced aggregation of androgen receptor in induced pluripotent stem cell-derived neurons from spinal and bulbar muscular atrophy.
Nihei Y; Ito D; Okada Y; Akamatsu W; Yagi T; Yoshizaki T; Okano H; Suzuki N
J Biol Chem; 2013 Mar; 288(12):8043-8052. PubMed ID: 23364790
[TBL] [Abstract][Full Text] [Related]
31. Human-Induced Pluripotent Stem Cell-Based Models for Studying Sex-Specific Differences in Neurodegenerative Diseases.
Kiris E
Adv Exp Med Biol; 2022; 1387():57-88. PubMed ID: 34921676
[TBL] [Abstract][Full Text] [Related]
32. CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics.
Sen T; Thummer RP
Neurotox Res; 2022 Oct; 40(5):1597-1623. PubMed ID: 36044181
[TBL] [Abstract][Full Text] [Related]
33. CRISPR/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells.
He L; Wang S; Peng L; Zhao H; Li S; Han X; Habimana JD; Chen Z; Wang C; Peng Y; Peng H; Xie Y; Lei L; Deng Q; Wan L; Wan N; Yuan H; Gong Y; Zou G; Li Z; Tang B; Jiang H
Transl Psychiatry; 2021 Sep; 11(1):479. PubMed ID: 34535635
[TBL] [Abstract][Full Text] [Related]
34. Biochemical Activity Architectures Visualized-Using Genetically Encoded Fluorescent Biosensors to Map the Spatial Boundaries of Signaling Compartments.
Mehta S; Zhang J
Acc Chem Res; 2021 May; 54(10):2409-2420. PubMed ID: 33949851
[TBL] [Abstract][Full Text] [Related]
35. The design and application of genetically encodable biosensors based on fluorescent proteins.
Newman RH; Zhang J
Methods Mol Biol; 2014; 1071():1-16. PubMed ID: 24052376
[TBL] [Abstract][Full Text] [Related]
36. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
[TBL] [Abstract][Full Text] [Related]
37. Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders.
de Rus Jacquet A; Denis HL; Cicchetti F; Alpaugh M
Mol Psychiatry; 2021 Jul; 26(7):2685-2706. PubMed ID: 33495544
[TBL] [Abstract][Full Text] [Related]
38. Genetically encoded fluorescent biosensors illuminate kinase signaling in cancer.
Lin W; Mehta S; Zhang J
J Biol Chem; 2019 Oct; 294(40):14814-14822. PubMed ID: 31434714
[TBL] [Abstract][Full Text] [Related]
39. Directly Reprogrammed Human Neurons to Understand Age-Related Energy Metabolism Impairment and Mitochondrial Dysfunction in Healthy Aging and Neurodegeneration.
Gudenschwager C; Chavez I; Cardenas C; Gonzalez-Billault C
Oxid Med Cell Longev; 2021; 2021():5586052. PubMed ID: 34950417
[TBL] [Abstract][Full Text] [Related]
40. Recent advances of induced pluripotent stem cells application in neurodegenerative diseases.
Amin N; Tan X; Ren Q; Zhu N; Botchway BOA; Hu Z; Fang M
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109674. PubMed ID: 31255650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
